ExcepGen
Solving fundamental problems in drug discovery to create a new generation of therapeutics.
Solving fundamental problems in drug discovery to create a new generation of therapeutics.
ExcepGen, a venture-backed, early stage biotechnology company based in San Francisco, is dedicated to tackling foundational issues in drug discovery. With a founding date of 2018, ExcepGen's mission is to revolutionize the field of therapeutics by addressing core challenges in drug discovery. The company's recent milestone includes a $4.00M Seed Round investment on 24 August 2023, with participation from notable investors such as RA Capital Management, Apollo Projects, ZAKA VC, Oxonian Ventures, and Gravity Fund. ExcepGen’s commitment to addressing critical obstacles in drug discovery and its recent funding round demonstrate significant potential for innovation and impact in the Biopharma, Biotechnology, Health Care, and Life Sciences sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $4.00M | 5 |
|
24 Aug 2023 |
| Seed Round | $25.00K | 1 |
|
01 Jul 2020 |
| Seed Round | $150.00K | 2 |
|
18 Mar 2019 |
We care about your data, and we'd love to use cookies make your experience better.
